1.0Avalere Health Advisoryhttps://advisory.avalerehealth.comrich600338<blockquote class="wp-embedded-content" data-secret="ZOtVSOqODX"><a href="https://advisory.avalerehealth.com/insights/fda-releases-final-guidance-on-pre-submission-program-for-medical-devices">FDA Releases Final Guidance on Pre-Submission Program for Medical Devices</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://advisory.avalerehealth.com/insights/fda-releases-final-guidance-on-pre-submission-program-for-medical-devices/embed#?secret=ZOtVSOqODX" width="600" height="338" title="“FDA Releases Final Guidance on Pre-Submission Program for Medical Devices” — Avalere Health Advisory" data-secret="ZOtVSOqODX" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script> /*! This file is auto-generated */ !function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document); </script> Originally established in 1995, the pre-IDE program provided applicants with a mechanism to obtain FDA feedback prior to their submission. Since 1995, the program grew to provide feedback on Premarket Approval (PMA) and Humanitarian Device Exemption (HDE) applications, Evaluation of Automatic Class III Designations (de novo petitions), Premarket Notification (510(k)) Submissions, Clinical Laboratory Improvement Amendments…